Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Phase I/II data reported for Millennium's humanized alpha4beta7 antibody

May 31, 2000

Z-338 tested in isolated opossum LES

May 31, 2000

Infliximab acts as steroid-sparing agent in Crohn's disease

May 30, 2000

BXT-51072 shows potent antioxidant activity in active ulcerative colitis

May 30, 2000

Herbal preparation shows promise in IBS

May 30, 2000

CDP-571 results in Crohn's disease presented at DDW

May 30, 2000

Shire buys rights to sell ulcerative colitis treatment in Europe

May 29, 2000

Clinical trial of Emitasol completed

May 29, 2000

Peginterferon alfa-2b monotherapy compared to standard interferon

May 26, 2000

PEGASYS BLA filed, clinical results reported and new study announced

May 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...